Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 1 von 988
Life Sciences, 1992, Vol.51 (2), p.83-94
1992
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants
Ist Teil von
  • Life Sciences, 1992, Vol.51 (2), p.83-94
Ort / Verlag
Amsterdam: Elsevier Inc
Erscheinungsjahr
1992
Quelle
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
Beschreibungen/Notizen
  • Several classes of drugs that modify serotonin (5-HT) neurotransmission are either currently used, or are being evaluated for their potential use in the treatment of anxiety, schizophrenia, and depression. 5-HT 1A agonists are considered potential anxiolytics, while some atypical antipsychotics are potent 5-HT 2 antagonists (and also have modest dopamine D 2 affinity). Furthermore, there is a diverse group of serotonergic drugs that may be effective antidepressants. Secretion of ACTH, corticosterone/cortisol, prolactin, renin, oxytocin and vasopressin are stimulated by activation of different 5-HT receptor subtypes, while other neurotransmitter receptors also influence the secretion of these hormones. We compared the receptor binding profiles of 5-HT anxiolytics, antipsychotics and antidepressants with their endocrine effects. These comparisons could aid in understanding both the therapeutic and side effects of these drugs.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX